Eric Pederson

Dr. Eric Pederson

Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, Massachusetts, USA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2019 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
EPEric Pederson
Eric Pederson
GIGianluca Interlandi
Gianluca Interlandi

24 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
TNTrang Uyen Nguyen
Trang Uyen Nguyen
Harrison HectorHarrison Hector
Harrison Hector
EPEric Pederson
Eric Pederson
JLJianan Lin
Jianan Lin
ZOZhengqing Ouyang
Zhengqing Ouyang
KSKamini Singh
Kamini Singh
Pancreatic cancer cells adapt molecular mechanisms to activate the protein synthesis to support tumor growth. This study reports the mTOR inhibitor rapamycin’s specific and genome-wide effect on mRNA translation. Using ribosome footprinting in pancreatic cancer cells that lack the expression of 4EBP1, we establish the effect of mTOR-S6-dependent mRNAs translation. Rapamycin inhibits the translation of a subset of mRNAs including p70-S6K and proteins involved in the cell cycle and cancer cell growth. In addition, we identify translation programs that are activated following mTOR inhibition. Interestingly, rapamycin treatment results in the translational activation of kinases that are involved in mTOR signaling such as p90-RSK1. We further show that phospho-AKT1 and phospho-eIF4E are upregulated following mTOR inhibition suggesting a feedback activation of translation by rapamycin. Next, targeting eIF4E and eIF4A-dependent translation by using specific eIF4A inhibitors in combination with rapamycin shows significant growth inhibition in pancreatic cancer cells. In short, we establish the specific effect of mTOR-S6 on translation in cells lacking 4EBP1 and show that mTOR inhibition leads to feedback activation of translation via AKT-RSK1-eIF4E signals. Therefore, targeting translation downstream of mTOR presents a more efficient therapeutic strategy in pancreatic cancer.

1 January 2025 in Cancer Informatics
Verified
Journal Article
Open access
BGBenjamin Goldberg
Benjamin Goldberg
EPEric Pederson
Eric Pederson
ZOZhengqing Ouyang
Zhengqing Ouyang
Objective: Breast cancer is one of the most prominent and deadly diseases in the world, and its prognosis varies widely based on the expression of certain genes. Identification of these genes is important for developing and interpreting clinical prognostic tests as well as furthering our understanding of breast cancer biology. We expand on prior efforts in the field toward identifying prognostic genes, by integrating powerful statistical methods. Methods: To this end, we use an unsupervised random forest model, which allows for robust learning of non-linear gene expression/survival relationships and the ability to identify the most important genes affecting both positive and negative breast cancer prognosis. In total, 1,518 participants were considered from the METABRIC dataset, using 20,387 mRNA expression level variables and 23 clinical variables including HER2 mutation status. The top 250 & bottom 250 expressing genes and 6 clinical features were selected for the unsupervised random forest model. Results: Our research corroborates previous discoveries of 27 important prognostic genes while also identifying 3 genes as potentially novel prognostic factors. Based on gene ontology analysis, we additionally show that these genes have plausible connections to breast cancer biology that should be experimentally investigated. Conclusions: Here, we demonstrate the utility of the unsupervised random forest model over K-means clustering for identifying important genes in breast cancer.

17 August 2025 in Bioinformatics and Biology Insights
Verified
Journal Article
Open access
SHScott Hebert
Scott Hebert
EPEric Pederson
Eric Pederson
ZOZhengqing Ouyang
Zhengqing Ouyang
Over 6 million people are estimated to have been living with Alzheimer disease (AD) in 2020, with another 12 million living with Mild Cognitive Impairment (MCI). Research has been conducted to evaluate genetic links to AD, but more research is needed to improve early disease detection and improve patient outcomes. Diagnostic, demographic information, and single nucleotide polymorphism (SNP) data were collected by the Alzheimer’s Disease Neuroimaging Initiative (ADNI). We performed LASSO regression with conditional selective inference to perform feature selection on the SNPs and other predictors (which included education, race, and marital status), which reduced the number of SNPs from 55 106 to 13 and removed all non-SNP predictors except years of education and marital status. The included SNPs reside in genes that have clinical significance and may be associated with diseases that affect cognitive performance. The results propose the alternative alleles for 7 SNPs are associated with increased risk of AD/MCI diagnosis, while 6 SNPs are associated with decreased risk of diagnosis. The results point to a new potential pathway of disease regarding the PAK5 gene and the Tau protein hypothesis, which is supported by previous research. This research may have clinical implications and should be further studied.